Svinkina T, Gu H, Silva JC, et al. Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow. Mol Cell Proteomics. 2015;14(9):2429-40. doi:10.1074/mcp.O114.047555
Maier VK, Feeney CM, Taylor JE, et al. Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator. Mol Cell Proteomics. 2015;14(6):1435-46. doi:10.1074/mcp.M114.044586
Sharma V, Eckels J, Taylor GK, et al. Panorama: a targeted proteomics knowledge base. J Proteome Res. 2014;13(9):4205-10. doi:10.1021/pr5006636
Fields AP, Rodriguez EH, Jovanovic M, et al. A Regression-Based Analysis of Ribosome-Profiling Data Reveals a Conserved Complexity to Mammalian Translation. Mol Cell. 2015;60(5):816-27. doi:10.1016/j.molcel.2015.11.013
Murray E, Cho JH, Goodwin D, et al. Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems. Cell. 2015;163(6):1500-14. doi:10.1016/j.cell.2015.11.025
Hoofnagle AN, Whiteaker JR, Carr SA, et al. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. Clin Chem. 2016;62(1):48-69. doi:10.1373/clinchem.2015.250563
Shu S, Lin CY, He HH, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529(7586):413-7. doi:10.1038/nature16508
Tabb DL, Wang X, Carr SA, et al. Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts. J Proteome Res. 2016;15(3):691-706. doi:10.1021/acs.jproteome.5b00859
Ruggles KV, Tang Z, Wang X, et al. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer. Mol Cell Proteomics. 2016;15(3):1060-71. doi:10.1074/mcp.M115.056226
Dimitrakopoulos L, Prassas I, Diamandis EP, et al. Proteogenomics: Opportunities and Caveats. Clin Chem. 2016;62(4):551-7. doi:10.1373/clinchem.2015.247858